Pulmonx Corp
corporate_fare Company Profile
Pulmonx Corp (NASDAQ:LUNG) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 15 items for LUNG at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-03, rated 7/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for LUNG spans 10-Q, 8-K, DEF 14A, 10-K.
Recent high-impact activity:
- Pulmonx 10-Q: Cash Falls to $52.7M, Perceptive Debt at 14% Effective Rate
- Pulmonx Posts 19-Cent Quarterly Loss as Micro-Cap Pressure Mounts
- Pulmonx Q2 Loss Narrows on Cost Cuts, but Revenue Slips 5%; CEO Adopts 10b5-1 Plan
- Pulmonx Q2 Revenue Falls 5% but Losses Narrow Sharply; Guidance Maintained
- Pulmonx Posts 24c Q2 Loss, Revenue Decline Deepens
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 787,512 shares in LUNG as of the October 30, 2026 settlement, a 12.7% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 31.9% of LUNG volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.